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ABSTRACT
The study aimed at verifying the associated factors of self-perceived body changes in adults living with HIV 
in highly-active antiretroviral therapy (HAART) in the city of São Paulo, Brazil. This cross-sectional study 
was conducted among people living with HIV on HAART for at least three months. A standardized question-
naire was used for assessing self-perceived body changes. Associated factors relating to self-reported body 
changes in people living with HIV (PLHIV) were assessed with Student’s t-test and chi-square test. In total, 
507 patients were evaluated. The mean time since diagnosis was 6.6 years [standard deviation (SD)±4.1], 
and the mean duration of HAART was 5.1 years (SD±3.3). Self-perceived body changes were reported by 
79.5% of the participants and were associated with viral load and duration of HAART. Fibre intake was 
lower among males who gained in abdominal fat (p=0.035). HAART-related body changes were reported by 
the large majority of the population and were associated with demographic and clinical variables.
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INTRODUCTION
Brazil, being the most populated country in Latin 
America, also holds one-third of all AIDS cases in 
the region. During 1980–June 2009, 544,846 cases 
of AIDS were noticed, corresponding to an inci-
dence rate of 18.2 per 100,000 inhabitants (1). Of 
the noticed cases, 65.4% were men, and 34.6% were 
women. According to the United Nations Joint Pro-
gramme on HIV/AIDS (UNAIDS), the number of 
infected people in the country varies from 600,000 
to 890,000 (2). São Paulo—the biggest city of Bra-
zil—has the largest number of people living with 
HIV (PLHIV) in the country.
In developed countries, the tendency of reduction 
in mortality due to AIDS had been observed even 
before the appearance of the highly-active antiret-
roviral therapy (HAART), and this has been attrib-
uted to the prophylaxis and better clinical treat-
ment of opportunistic infections. However, with 
the use of protease inhibitors, this phenomenon 
was accentuated (3).
Ever since universal access to HAART through the 
public-health system in Brazil (in 1996), the country 
has become an example for the treatment of those 
living with HIV. The public-healthcare programme 
for PLHIV also includes other initiatives aimed at 
reducing hospital admissions, such as specialized 
outpatient care, day hospitals, and home-based 
care (3). Consequently, the rate of HIV infection-
related mortality has declined from 9.6 per 100,000 
inhabitants in 1996 to 6.1 per 100,000 inhabitants 
in 2008, resulting in increases in survival (1). 
With great progress in the clinical course, prog-
nostic and survival of patients, HIV infection starts 
to be seen like a disease of chronic evolution and 
potentially controllable (4). The prolonged use of 
HAART has led to side-effects which have brought 
new demands to health services specialized in the 
care of PLHIV (5).
Lipodystrophy syndrome, defined as a set of chang-
es that includes loss of fat in peripheral areas, such 
as face, buttocks, arms, and legs, and gain in fat 
in central portions of the body, such as abdomen, 
neck, and chest and in the arms, is currently con-
sidered one of the most important side-effects of 
the use of HAART that may lead to other problems 
relating to stigma towards PLHIV (6). In a study 
among HAART users, perceived body changes were 
significantly associated with the duration of the use 
of protease inhibitors and nucleoside reverse tran-
scriptase inhibitors (6).Giudici KV et al.
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The fact that not all patients on HAART develop fat 
redistribution, dyslipidaemia, or impaired glucose 
homeostasis supports the hypothesis that the sus-
ceptibility to morphologic and metabolic changes 
varies by therapy, environment, and genetics (7). In 
a study on self-reported body changes, Santos et al. 
found a prevalence of 49.2% of self-perception of 
gain in abdominal fat in PLHIV in Brazil (6). Over-
weight and obesity are turning into a major pub- 
lic-health concern in the country, reaching 45% 
of Brazilian adults in 2003 (8). The rates of obesity 
among men and women increased by 92% and 
63% between 1975 and 1989 respectively, and be-
tween 1989 and 2003, a further rise was observed—
10% among women and 26% among men, even 
higher among lower-income groups (9).
The role of an adequate intake of fibres in the preven-
tion of diseases is already well-known (10). Benefits, 
among others, included reduction of lipid concentra-
tions in blood, better tolerance to glucose, reduc-
tion of hyperinsulinaemia, control of body-weight, 
better gastrointestinal function, and reduction in 
the risk of cardiovascular diseases. Therefore, this 
study aimed at verifying the associated factors relat-
ing to self-reported body changes in PLHIV receiving 
HAART in the city of São Paulo, Brazil.
MATERIALS AND METHODS
Sample
Data from participants of this cross-sectional study 
were collected in nine of 15 STD/AIDS Specialized 
Health Community Centres of the City Council 
STD/AIDS Programme. These health community 
centres were located at four different geographic re-
gions of the city of São Paulo, and there were no dif-
ferences in the socioeconomic characteristics when 
the included health centres were compared with 
those excluded due to infrastructural problems.
Adults, aged 20-59 years, living with HIV, who had 
been on HAART for at least three months, were in-
vited to join the study. Pregnant women and those 
who had undergone aesthetic surgery in the last six 
months (except for facial fill surgery) were excluded. 
Participants were chosen using a consecutive cumu-
lative approach during November 2007–June 2008. 
Collection of data
A standardized questionnaire was used for collect-
ing demographic data on age and schooling. Clini-
cal data, which included CD4 cell count (cells/mm3) 
analyzed by flow cytometry (FACS Calibur, BD) 
and viral load (copies/mL) measured by branched 
DNA assay (Versant 440, Siemens), were obtained 
from the medical records of the participants, with 
a maximum time interval of six months before and 
after the interview day. Viral load was analyzed as a 
dichotomous variable with a considered threshold 
of 50 copies/mL. Information on the duration of 
known HIV infection and of HAART-use was also ob-
tained from the medical records of the participants.
Body mass index (BMI) was used for characterizing 
the nutritional status of the study population, and 
it was estimated from corrected measures of height 
and weight. The methodology for the study has 
been validated and published elsewhere (11).
Of 540 persons interviewed, 32 were excluded be-
cause they were considered important outliers (be-
low percentile 3 and above percentile 97 for the total 
energy intake). One participant was excluded from 
the sample because he did not answer all questions 
regarding self-perception of body changes. Data on 
507 individuals were analyzed. The sample-size for 
the analyses of CD4 cell count and viral load was 
501 and 473 respectively due to missing values.
Detailed description of types of foods and amount 
consumed the day before the interview was ob-
tained using a rigorous standardization and was 
included individually in the nutritional software 
NutWin (DIS-EPM, São Paulo, Brazil). Standardiza-
tions were based on Brazilian guides (12,13).
Dietary variables studied were: energy, carbohy-
drate, fibre, protein, total fat, and saturated fat. Fi-
bre intake was corrected by the total energy intake 
using the residual method (14).
Reported self-perception of body changes was de-
fined based on the answer provided to the ques-
tion, addressing the self-perception of an increase 
or reduction of whatever severity in at least one 
specific body part, including face, buttock, arms, 
legs, neck, chest, and abdomen. 
The sample was divided into two groups: those 
who reported any gain in body fat or loss of fat or 
lean mass, and those who did not report any body 
change. Frequency of self-reported body changes 
was described by the percent distribution of each 
of the cited groups of distinct patterns of change 
stratified by gender. Such groups were compared by 
demographic factors (schooling and age) and clini-
cal factors (TCD4+ cells, viral load, time since diag-
nosis of HIV, and duration of HAART). 
BMI and food intake of the study population (ener-
gy, macronutrients, saturated fat, dietary fibre, and 
density of fibre intake—dietary fibre (g)/1,000 kcal) Giudici KV  et al. Self-reported body changes in people with HIV
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were compared according to the presence of any 
perceived body change; any perceived gain in body 
fat; and any perceived fat or lean mass loss. 
After interviews, all the participants received brief 
nutritional counselling for promoting healthful eat-
ing, physical activity, and prevention of biochemi-
cal and morphological changes, in agreement with 
the recommendations of the Dietary Guidelines 
for the Brazilian Population (15) and Nutritional 
Recommendations to Individuals Living with HIV/
AIDS (16). They were also referred to dietitians of 
the STD/AIDS Specialized Health Community Cen-
tres, if necessary.
Analysis of data
Student’s t-test was used for continuous variables, 
and categorical variables were analyzed by Pearson’s 
chi-square test. 95% confidence interval (CI) was car-
ried out to estimate the significant prevalence of self-
reported body changes. Associations between the 
mean dietary fibre intake and the self-reported body 
changes were assessed with the Student’s t-test. Sta-
tistical analyses were performed using the SPSS soft-
ware (version 13.0) (SPSS Inc., Chicago, IL, USA).
Ethics
Patients who agreed to participate were admitted 
after they signed an informed consent form and 
were fully informed about the objectives and pro-
cedures of the research. The Ethics Committees of 
both School of Public Health of the University of 
São Paulo and Health Secretariat of the municipali-
ty of São Paulo approved the study. Anonymity of 
subjects and confidentiality of information were 
ensured at all times.
RESULTS
In total, 507 patients were evaluated, and their 
mean age was 41.7 years [standard deviation 
(SD)±7.8], of which 57.8% were male. The mean 
time since diagnosis was 6.6 years (SD±4.1), and 
the mean duration of antiretroviral treatment was 
5.1 years (SD±3.3) (Table 1).
Table 1. Characteristics of the study sample. São Paulo, Brazil, 2008
Characteristics
Total Male Female
No. %† No. %† No. %†
Age (years)‡
   20-29 33 6.5 18 6.1 15 7.0
   30-39 182 35.9 96 32.8 86 40.2
   40-49 210 41.4 124 42.3 86 40.2
   >50 82 16.2 55 18.8 27 12.6
Schooling (years)‡
   <8 274 54.2 148 50.7 126 58.9*
   8-11 173 34.2 99 33.9 74 34.6
   >11 59 11.7 45 15.4 14 6.5
TCD4+ cells  (cells/mm³)‡
   <200 86 17.2 49 16.8 37 17.6
   200-499 222 44.3 138 47.4 84 40.0
   ≥500 193 38.5 104 35.7 89 42.4
Viral load‡
Undetectable 137 29.0 76 26.9 61 32.1
Detectable 336 71.0 207 73.1 129 67.9
BMI‡
   <18.5 26 5.4 7 2.5 19 9.8*
   18.5-24.99 288 60.3 178 62.5 110 57.0
   25-29.99 130 27.2 87 30.5 43 22.3
   ≥30 34 7.1 13 4.5 21 10.9
Time since HIV diagnosis 
(years)¶,$ 6.61
 
4.08 6.35
 
4.14 6.97
 
3.97
Duration of HAART 
(years)¶,$ 5.11
 
3.30 5.10
 
3.27 5.12
 
3.35
*p<0.05; †Except where indicated otherwise; ‡Pearson’s chi-square test; ¶Student’s t-test; $Mean (standard 
deviation); BMI=Body mass index; HAART=Highly-active antiretroviral therapyGiudici KV et al.
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Of the participants, 54.2% had eight or less years of 
schooling, and women had lower schooling rates 
than men (p=0.007). Of the men (n=293), 35.0% 
were considered overweight (BMI ≥25) while 33.2% 
of the women (n=214) had a BMI of ≥25. More 
women than men were considered underweight 
(p<0.001).
Of the study subjects, 403 (79.5%) reported self-
perception of body changes after the initiation of 
HAART. Loss of body fat or lean mass was reported 
by 54.6% [confidence interval (CI) 95% 50.3-59.0] of 
the patients, and 59.2% (CI 95% 54.9-63.5) report-
ed gain in body fat. The self-perceived prevalence of 
body changes was higher among women (83.6%, 
CI 95% 78.6-88.6) compared to men (76.5%, 
CI 95% 71.6-81.3) (p=0.048). Gain in abdominal fat 
was perceived by 53.5% of the participants.
Those who reported any body change had been re-
ceiving HAART for a longer period than those who 
did not (p=0,035) (Table 2). Of the participants who 
reported gain in fat or loss of fat or lean mass in 
at least one body part, 31.6% presented undetect-
able viral load while the same was seen in 18.7% of 
those who did not perceive it (p=0.013).
The mean BMI was higher among persons who re-
lated gain in body fat (24.5; SD±3.8; p<0.001) and 
lower among those who related loss of any body fat 
or lean mass (BMI 23.3 vs 24.6; p<0.001) (Table 3).
Although no associations were found in the com-
parisons of those who perceived and who did not 
perceive any body change in food intake (Table 3), 
men who reported gain in abdominal fat reported 
a lower fibre intake (25.6 g; SD±11.2 g vs 28.5 g per 
day; SD±12.1 g; p=0.035) (Fig.).
DISCUSSION
Self-perception is one of the most-used methods to 
assess the HAART-related body changes (6,17). 
The prevalence of self-perceived body changes was 
higher in this population than that found by San-
tos et al. previously in Brazil (64.3%) (6). Tien et al. 
reported that the mean prevalence of body changes 
in PLHIV varied between 30% and 62% in a review 
study (17). The prevalence of body changes among 
patients living with HIV reported in the literature 
shows a great variation, mostly as a result of the 
different case definitions adopted by researchers. 
Santos et al. believe that the association between 
self-perceived body changes and schooling may 
be a result of better access to information on treat-
ment and its implications (6).
The prevalence of self-reported body changes was 
significantly higher among women. This finding 
can perhaps be explained by the fact that women 
are usually more susceptible to present self-image 
distortions, compared to men, due to the cultural 
and psychosocial factors that influence and deter-
mine the construction of body image (18).
Undetectable viral load was more prevalent among 
Table 2. Clinical and demographic characteristics of adults living with HIV according to self-perception 
of HAART-related body changes, São Paulo, Brazil, 2008
Characteristics
Any body change
(gain in fat or loss in fat or lean mass)
Yes No
No. %† No. %†
TCD4+ cells (cells/mm³)‡
   <200 68 17.1 18 17.3
   200-499 180 45.4 42 40.4
   ≥500 149 37.5 44 42.3
Viral load (copies/mL)‡
   Undetectable 119 31.6 18 18.7*
   Detectable 258 68.4 78 81.3
Time (years) since diagnosis¶,$ 6.68 4.04 6.33 4.23
Duration (years) of HAART¶,$ 5.27 3.39 4.47 2.85*
Age (years)¶,$ 41.90 7.77 41.02 8.07
Schooling (years)¶,$ 8.27 3.65 8.19 4.05
*p<0.05; †Except where indicated otherwise; ‡Pearson’s chi-square test; ¶Student’s t-test; $Mean (standard 
deviation); HAART=Highly-active antiretroviral therapyGiudici KV  et al. Self-reported body changes in people with HIV
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those who perceived any body change, and the 
mean duration of HAART was also higher among 
this subpopulation. Some studies, based either on 
clinical diagnosis of lipodystrophy or on self-re-
ported perception of body changes, found associa-
tions between the self-perceived body changes and 
the use of antiretroviral drugs, along with the dura-
tion of use of the nucleoside reverse transcriptase 
inhibitors and protease inhibitors (19,20).
In the present study, the mean fibre intake was 
significantly lower among men who related gain 
in abdominal fat after beginning HAART-use, cor-
roborating previous findings (21). Nonetheless, the 
mean fibre intake in all the subgroups was above 
the recommendations for the Brazilian population, 
which is 25 g per day (15). Hendricks et al. showed 
that persons with fat deposition were observed to 
consume lower amounts of total fibres, soluble 
fibres, insoluble fibres, and pectin (22). However, 
this same group did not reach the recommended 
dietetic fibre levels stated by the American Dietetic 
Association (23).
Besides studying fibre intake, the present study 
analyzed other nutrients, such as protein, carbohy-
drate, total fat, and saturated fat. All the values were 
within the recommendations for healthy Brazilian 
adults (15). It is widely known that a saturated fat-
rich diet leads to hyperlipidemy and increases the 
risk of cardiovascular diseases (24). In this study, 
saturated fat intake met the guidelines—results not 
found by Hendricks et al. (22,25).
Only schooling and BMI differed when men and 
women were compared. Schooling is a proxy of so-
Fig. Association between energy and adjusted
       dietary ﬁbre intake and self-reported gain
       in abdominal fat in adults living with HIV,
       São Paulo, Brazil, 2008
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Table 3. Dietary intake and nutritional status of adults living with HIV according to self-perception of 
HAART-related body changes, São Paulo, Brazil, 2008
Nutrients and nutri-
tional status
Any body change (gain in fat 
or loss in fat or lean mass)
Gain in body fat 
Loss in body fat or 
lean mass 
Yes No Yes No Yes No
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Energy (kcal)  2,357.77 
(960.65)
2,452.16 
(987.30)
2,355.36 
(959.03)
2,408.69 
(977.33)
2,382.91 
(979.42)
2,370.17 
(951.53)
Carbohydrates†  53.77 
(11.46)
54.64 
(9.81)
53.85 
(10.98)
55.47 
(10.21)
54.71 
(11.26)
54.27 
(9.98)
Proteins†  17.84 
(5.56)
17.62 
(5.26)
18.08 
(5.76)
17.52 
(5.47)
17.86 
(5.89)
17.84 
(5.34)
Total fat†  27.66 
(8.59)
27.51 
(8.50)
28.08 
(8.65)
27.01 
(8.41)
27.43 
(8.39)
27.89 
(8.77)
Saturated fat†  8.71 
(4.42)
8.74 
(4.53)
8.87 
(4.64)
8.52 
(4.15)
8.61 
(4.44)
8.86 
(4.45)
Dietary fibre (g)$  25.23 
(11.02)
27.29 
(11.52)
25.29 
(11.04)
26.17 
(11.29)
25.55 
(11.15)
25.77 
(11.16)
Density (dietary fibre 
(g) per 1,000 kcal)
11.29
(5.18)
11.84
(5.11)
11.28 
(5.22)
11.60
(5.08)
11.28
(4.97)
11.56
(5.40)
BMI‡   23.86 
(3.79) 
23.87 
(3.90)
24.50 
(3.78) 
22.92 
(3.66)*
23.25 
(3.42)
24.61 
(4.12)*
*p<0.05; †Percentage of total energy intake; $Adjusted by total energy intake; BMI=Body mass index; 
SD=Standard deviationGiudici KV et al.
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cioeconomic status, which may lead us to conclude 
that the PLHIV with lower schooling years may be 
facing worse life-conditions, negatively impacting 
self-care and adherence (26). In this population, 
women presented lower schooling levels than 
men.
Corroborating the previous finding, the prevalence 
of overweight (BMI >25.0) was higher than the 
prevalence of underweight (BMI <18.5). The preva-
lence of overweight in the United States has been 
observed among more than 50% of both men and 
women living with HIV (27). In a sample of 223 
Brazilians living with HIV, 36.5% of women (n=19) 
and 28.6% of men (n=49) were considered over-
weight while 7.7% and 2.3% had a BMI of <18,5 
(14). Furthermore, gain in body-fat was more prev-
alent among those with a higher BMI, and loss of 
fat or lean mass was more prevalent among those 
with a lower BMI, reinforcing the use of self-report-
ed techniques to estimate the prevalence of body 
changes among PLHIV.
Limitations
Choosing to use a 24-hour food recall can be seen 
as a limitation of the present study. However, it is 
a feasible instrument to estimate the mean values 
of food intake from a population group. Still, the 
sample-size of the present study can be seen as its 
strength. Care was taken when selecting individu-
als from different STD/AIDS Specialized Health 
Community Centres. 
Since it was as a cross-sectional study, a further 
evaluation linked to the temporal framework was 
not possible. Despite this, it is believed that these 
findings can contribute to future improvements re-
lating to the care of PLHIV.
Conclusions
A high prevalence of self-perceived body changes 
has been reported in the population studied, es-
pecially in women, and an association was found 
between the self-perceived body changes and viral 
load and the duration of HAART. Similar results 
were observed in previous studies, contributing to 
building the importance of public-health policies 
aimed at reducing the prevalence of HAART-related 
body changes, providing aid in facing common is-
sues relating to the disease and its treatment and, 
finally, improving the quality of life among PLHIV. 
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